文献速递术前评估与围术期医学疼痛医学

无阿片麻醉减少胸腔镜肺切除术后恶心呕吐:随机对照试验

Opioid-free anaesthesia reduces postoperative nausea and vomiting after thoracoscopic lung resection: a randomised controlled trial.
PubMed 文献 · Br J Anaesth · 2023-12-01

这项随机对照试验纳入120例成人胸腔镜肺切除术患者,比较无阿片麻醉(OFA,艾司氯胺酮+右美托咪定+七氟烷)与阿片麻醉(舒芬太尼+七氟烷)对术后48小时内恶心呕吐(PONV)的影响。OFA组PONV发生率为15%,阿片组为31.7%,OR=0.38(95%CI 0.16-0.91),P=0.031,NNT=6。OFA组呕吐率更低但PACU停留时间更长。

要点

  • 在PONV预防和多模式镇痛背景下,OFA使PONV发生率减半
  • OFA组呕吐率更低(OR=0.23),但PACU停留时间延长15.5分钟
  • OFA对PONV的影响在性别、吸烟状态和PONV风险评分亚组中无差异

核心结论

  • 在PONV预防和多模式镇痛背景下,SPI引导的无阿片麻醉使胸腔镜肺切除术后PONV发生率减半,但PACU停留时间延长。

研究设计与样本

  • 随机对照试验,120例成人胸腔镜肺切除术患者按1:1随机分组(按性别分层),分别接受OFA(艾司氯胺酮+右美托咪定+七氟烷)或阿片麻醉(舒芬太尼+七氟烷)。
  • 术中镇痛依据手术体积描记指数(SPI)20-50进行调节。
  • 所有患者均接受PONV预防(地塞米松+昂丹司琼)和多模式镇痛(氟比洛芬酯+罗哌卡因伤口浸润+舒芬太尼患者自控镇痛)。

主要发现

  • OFA组PONV发生率为15%,阿片组为31.7%,OR=0.38(95%CI 0.16-0.91),NNT=6,P=0.031。
  • OFA组呕吐率更低,OR=0.23(95%CI 0.08-0.77)。
  • OFA组PACU停留时间更长,中位差异15.5分钟(95%CI 10-20分钟)。
  • 次要结局和安全性结局两组间具有可比性。
  • OFA对PONV的影响在性别、吸烟状态和PONV风险评分预设亚组中无差异。

关键数值与推荐

  • 主要结局为术后48小时内PONV的发生率。
  • OFA组PONV发生率15%,阿片组31.7%,OR=0.38(95%CI 0.16-0.91),P=0.031,NNT=6。
  • 呕吐OR=0.23(95%CI 0.08-0.77),PACU停留时间中位差异15.5分钟(95%CI 10-20分钟)。

临床怎么用

  • 对于胸腔镜肺切除术患者,在实施PONV预防和多模式镇痛时,可考虑采用SPI引导的无阿片麻醉以降低PONV发生率。
  • 需注意无阿片麻醉可能延长PACU停留时间,应做好PACU资源安排。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intraoperative opioid use has a positive relationship with postoperative nausea and vomiting (PONV), and opioid-free anaesthesia (OFA) might reduce PONV. We investigated whether OFA compared with opioid-based anaesthesia would reduce PONV during the first 2 postoperative days among patients undergoing thoracoscopic lung resection. METHODS: In this randomised controlled trial, 120 adult patients were randomly assigned (1:1, stratified by sex) to receive either OFA with esketamine, dexmedetomidine, and sevoflurane, or opioid-based anaesthesia with sufentanil and sevoflurane. A surgical pleth index (SPI) of 20-50 was applied for intraoperative analgesia provision. All subjects received PONV prophylaxis (dexamethasone and ondansetron) and multimodal analgesia (flurbiprofen axetil, ropivacaine wound infiltration, and patient-controlled sufentanil). The primary outcome was the occurrence of PONV during the first 48 h after surgery. RESULTS: The median age was 53 yr and 66.7% were female. Compared with opioid-based anaesthesia, OFA significantly reduced the incidence of PONV (15% vs 31.7%; odds ratio [OR]=0.38, 95% confidence interval [CI], 0.16-0.91; number needed to treat, 6; P=0.031). Secondary and safety outcomes were comparable between groups, except that OFA led to a lower rate of vomiting (OR=0.23, 95% CI, 0.08-0.77) and a longer length of PACU stay (median difference=15.5 min, 95% CI, 10-20 min). The effects of OFA on PONV did not differ in the prespecified subgroups of sex, smoking status, and PONV risk scores. CONCLUSIONS: In the context of PONV prophylaxis and multimodal analgesia, SPI-guided opioid-free anaesthesia halved the incidence of PONV after thoracoscopic lung resection, although it was associated with a longer stay in the PACU. CLINICAL TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR2200059710).

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Feng CD, Xu Y, Chen S, et al. Opioid-free anaesthesia reduces postoperative nausea and vomiting after thoracoscopic lung resection: a randomised controlled trial. Br J Anaesth. 2023. PMID: 38042725. doi:10.1016/j.bja.2023.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。